Sanofi Income Statement (2009-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Revenue & cost
Revenue (Quarter)	12.30B	31.76B	10.86B	10.79B	12.59B	32.93B	10.97B	10.85B	13.02B	40.69B	9.70B	10.15B	13.35B	6.88B	10.41B	11.31B	37.79B	-9.99B	12.30B	13.48B
Cost of Revenue (Quarter)	3.82B	10.04B	3.23B	3.47B	3.86B	13.97B	3.30B	3.56B	4.18B	13.59B	3.23B	3.23B	4.02B	14.11B	3.04B	3.39B	10.86B	15.19B	3.67B	3.51B
Gross Profit (Quarter)	8.95B	22.86B	8.05B	7.99B	9.38B	24.46B	8.35B	8.07B	9.64B	31.19B	7.34B	7.72B	10.23B	5.73B	8.12B	8.76B	29.48B	-8.16B	9.49B	10.79B
Operating items
Amortization - Intangibles (Quarter)	-0.45B	-1.81B	-0.50B	-0.49B	-0.69B	-2.09B	-0.52B	-0.59B	-0.61B	-2.06B	-0.53B	-0.45B	-0.44B	-0.47B	-0.03B	-0.85B	-1.45B	-2.61B	-0.11B	-1.15B
Depreciation & Amortization - Total (Quarter)
Research & Development (Quarter)	-1.70B	-4.70B	-1.67B	-1.77B	-1.75B	-4.98B	-1.68B	-1.77B	-1.81B	-7.00B	-1.81B	-1.79B	-1.98B	-7.90B	-1.90B	-2.16B	-6.49B	-9.13B	-2.05B	-2.60B
Selling, General & Administrative (Quarter)	-2.67B	-7.78B	-2.67B	-2.75B	-2.67B	-10.70B	-2.80B	-2.80B	-2.81B	-9.61B	-2.29B	-2.36B	-2.45B	-9.81B	-2.34B	-2.59B	-7.95B	-11.11B	-2.72B	-2.87B
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)										-2.66B	-0.66B		-1.09B	-2.57B	-0.87B		-3.79B	1.43B	0.33B	0.60B
Operating Expenses (Quarter)	-4.38B	-12.47B	-4.34B	-4.52B	-4.42B	-15.69B	-4.48B	-4.58B	-4.62B	-16.61B	-4.11B	-4.15B	-4.43B	-17.71B	-4.24B	-4.75B	-14.44B	-20.24B	-4.77B	-5.46B
Operating Income (Quarter)	13.33B	35.33B	12.39B	12.51B	13.80B	40.14B	12.83B	12.65B	14.26B	47.80B	11.45B	11.87B	14.66B	23.44B	12.36B	13.51B	43.92B	12.08B	14.26B	16.25B
EBIT (Quarter)	13.33B	35.33B	12.39B	12.51B	13.80B	40.14B	12.83B	12.65B	14.26B	47.80B	11.45B	11.87B	14.66B	23.44B	12.36B	13.51B	43.92B	12.08B	14.26B	16.25B
Non-operating items
Interest & Investment Income (Quarter)														-0.11B	0.01B	0.20B		0.03B	-0.03B	0.09B
Other Non Operating Income (Quarter)														-0.19B	-0.05B			0.40B	-0.06B
Non Operating Income (Quarter)
Net income details
EBT (Quarter)	13.43B	-0.02B	12.49B	12.62B	13.90B	40.44B	13.01B	12.87B	14.61B	49.20B	11.72B	10.98B	14.94B	4.87B	12.59B	13.77B	44.60B	12.76B	14.44B	16.58B
Tax Provisions (Quarter)	-0.71B	-1.78B	-0.37B	-0.17B	-0.61B	-1.12B	-0.49B	-0.30B	-0.61B	-1.09B	-0.11B	-0.30B	-0.75B	-1.29B	-0.51B	-0.26B	-1.63B	-1.21B	-0.49B	-0.52B
Profit After Tax (Quarter)	2.75B	5.86B	2.26B	1.30B	2.10B	5.42B	2.16B	1.58B	2.76B	2.13B	1.24B	1.20B	3.12B	3.59B	1.99B	4.46B	10.11B	-7.72B	1.90B	0.44B
Equity Income (Quarter)	3.48B	7.30B	2.60B	-2.53B	2.70B	6.48B	2.64B	-2.73B	3.30B	6.73B	1.23B	-1.12B	3.75B	7.16B	2.27B	0.01B	8.29B	7.19B	2.35B	-2.22B
Net Income - Minority (Quarter)
Income from Non-Controlling Interests (Quarter)	0.03B	0.05B	0.01B	-0.08B	0.00B	0.12B	0.02B	0.01B	0.01B	-0.00B	0.01B	-0.04B	0.03B	0.01B	0.02B	-0.05B	0.04B	0.04B	0.01B	0.04B
Income from Continuing Operations (Quarter)	14.14B	1.77B	12.86B	12.79B	14.51B	41.56B	13.50B	13.17B	15.22B	50.29B	11.83B	11.27B	15.69B	6.15B	13.09B	14.03B	46.23B	13.97B	14.93B	17.11B
Consolidated Net Income (Quarter)	14.14B	1.77B	12.86B	12.79B	14.51B	41.56B	13.50B	13.17B	15.22B	-0.47B	0.17B	0.05B	0.04B	-0.19B	0.18B	3.06B	3.34B	-3.34B	0.03B
Income towards Parent Company (Quarter)	2.72B	5.80B	2.25B	1.25B	2.09B	5.37B	2.14B	1.56B	2.75B	-0.60B	1.23B	1.20B	3.09B	0.53B	1.97B	4.46B	10.07B	-7.70B	1.89B	-7.60B
Net Income towards Common Stockholders (Quarter)	2.72B	5.80B	2.25B	1.25B	2.09B	5.37B	2.14B	1.56B	2.75B	-0.60B	1.23B	1.20B	3.09B	0.53B	1.97B	4.46B	10.07B	-7.70B	1.89B	-7.60B
Additional items
EPS (Basic) (Quarter)	2.17	4.63	1.80	1.00	1.67	4.29	1.71	1.25	2.19	-0.48	0.99	0.96	2.47	0.43	1.60	3.64	8.23	-6.31	1.57	-6.35
EPS (Diluted) (Quarter)	2.17	4.61	1.79	1.00	1.67	4.27	1.70	1.25	2.19	-0.48	0.98	0.96	2.47	0.42	1.57	3.62	8.18	-6.28	1.54	-6.30
Shares Outstanding (Quarter)	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.23B	1.23B	1.22B	1.22B	1.20B	1.20B
Shares Outstanding (Diluted) (Quarter)	1.26B	1.26B	1.26B	1.26B	1.26B	1.26B	1.26B	1.25B	1.25B	1.26B	1.26B	1.25B	1.25B	1.26B	1.26B	1.23B	1.23B	1.23B	1.23B	1.21B
Shares Outstanding (Entity) (Quarter)	1.25B	1.26B	1.25B	1.27B	1.25B	1.26B	1.25B	1.26B	1.25B	1.26B	1.25B	1.27B	1.25B	1.26B	1.23B	1.23B	1.22B	1.22B	1.20B	1.21B
EBITDA (Quarter)	13.33B	35.33B	12.39B	12.51B	13.80B	40.14B	12.83B	12.65B	14.26B	47.80B	11.45B	11.87B	14.66B	23.44B	12.36B	13.51B	43.92B	12.08B	14.26B	16.25B
Interest Expenses (Quarter)	-0.10B	-0.42B	-0.10B	-0.11B	-0.10B	-0.30B	-0.18B	-0.22B	-0.35B	-1.39B	-0.27B	0.89B	-0.28B	-1.15B	-0.22B	-0.05B	-0.69B	-0.66B	-0.21B	-0.33B
Tax Rate (Quarter)	-5.32%	10,671.23%	-2.98%	-1.38%	-4.36%	-2.76%	-3.79%	-2.29%	-4.20%	-2.22%	-0.96%	-2.70%	-5.03%	-26.44%	-4.02%	-1.89%	-3.65%	-9.52%	-3.41%	-3.16%

Research Tools

Datasets

Plans

Developers

Sanofi SNYNF Income Statement (2009-2026)

Research Tools

Datasets

Plans

Developers

Sanofi SNYNF Income Statement (2009-2026)

Create an account

Sign In

Reset Password